CALLAHAN KYLE J 4
4 · ACCREDO HEALTH INC · Filed Aug 19, 2005
Insider Transaction Report
Form 4
CALLAHAN KYLE J
Sr. Vice President
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2005-08-18−37,500→ 0 totalExercise: $32.87Exp: 2012-09-03→ Common Stock (37,500 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2005-08-18−26,000→ 0 totalExercise: $23.59Exp: 2014-09-08→ Common Stock (26,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2005-08-18−90,002→ 0 totalExercise: $18.50Exp: 2010-11-01→ Common Stock (90,002 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2005-08-18−39,000→ 0 totalExercise: $26.55Exp: 2014-12-13→ Common Stock (39,000 underlying) - Disposition to Issuer
Common Stock
2005-08-18−149,787→ 0 total
Footnotes (6)
- [F1]The shares were disposed of pursuant to the merger agreement between Medco Health Solutions, Inc. ("Medco") and the issuer in exchange for $22.00 in cash plus 0.49107 shares of Medco common stock per share of issuer common stock. The Medco common stock had a market value of $49.42 per share on the effective date of the merger.
- [F2]This option, which was fully vested, was assumed by Medco in the merger and replaced with an option to purchase 84,086 shares of Medco common stock for $19.81 per share.
- [F3]This option, which became fully vested pursuant to the merger agreement, was assumed by Medco in the merger and replaced with an option to purchase 35,035 shares of Medco common stock for $35.18 per share.
- [F4]This option, which became fully vested pursuant to the merger agreement, was assumed by Medco in the merger and replaced with an option to purchase 35,035 shares of Medco common stock for $29.88 per share.
- [F5]This option, which became fully vested pursuant to the merger agreement, was assumed by Medco in the merger and replaced with an option to purchase 24,291 shares of Medco common stock for $25.25 per share.
- [F6]This option, which became fully vested pursuant to the merger agreement, was assumed by Medco in the merger and replaced with an option to purchase 36,436 shares of Medco common stock for $28.42 per share.